Facts of Romidepsin
Product: Romidepsin for injection For intravenous infusion only
Indication: T-cell lymphoma affecting the skin (cutaneous T-cell lymphoma, or CTCL).
Strength: For injection, 10 mg, supplied with one Diluent vial containing 2 mL (deliverable volume) of solution
Company: Gloucester Pharmaceuticals, Inc.
South Delhi Pharma can facilitate patients and physicians access to commercially approved medicines, “Romidepsin” to all locations in the world and in India after fulfilling the legal requirement (if applicable). Romidepsin is a prescription drug and should be used under proper medical guidance and advice. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Get In Touch
Get in touch with us at South Delhi Pharma (SDP), and one of our team will be on hand to help with any queries you may have.
The SDM is open
Monday to Friday.
Business hours: 09:30 A.M to 18:30 P.M.
M:+91-9891296838 / P:+91-11- 26532129
What Romidepsin is?
Romidepsin, is an anticancer agent used in cutaneous T-cell lymphoma (CTCL) and other peripheral T-cell lymphomas (PTCLs). Romidepsin is a natural product obtained from the bacterium Chromobacterium violaceum, and works by blocking enzymes known as histone deacetylases, thus inducing apoptosis. It is sometimes referred to as depsipeptide, after the class of molecules to which it belongs.